omalizumab

Italy

Drugs containing this active substance

  • OMYLCLO

    Omlyclo is used for the treatment of severe allergic asthma (in adults, adolescents, and children aged 6 years and older), chronic rhinosinusitis with nasal polyps (in adults aged 18 years and older), and chronic spontaneous urticaria (in adults and adolescents aged 12 years and older).

    Form: solution for injection in pre-filled syringe

    Active substance Dosage
    omalizumab -

    ATC: R03DX05

    Manufacturer: CELLTRION HEALTHCARE HUNGARY KFT

  • XOLAIR

    This medicine is used for the treatment of severe allergic asthma, chronic rhinosinusitis with nasal polyps, and chronic spontaneous urticaria (CSU).

    Form: solution for injection, powder and solvent

    Active substance Dosage
    omalizumab -

    ATC: R03DX05

    Manufacturer: NOVARTIS EUROPHARM LIMITED